Amneal Pharmaceuticals (AMRX) Dividends Paid - Common (2017 - 2018)

Amneal Pharmaceuticals' (AMRX) quarterly Dividends Paid - Common came in at $153.0 million in Q2 2018, up 409.99% quarter-over-quarter from $30.0 million in Q1 2018.

Amneal Pharmaceuticals (AMRX) Dividends Paid - Common (2017 - 2018) Analysis & Trends

Amneal Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $153.0 million for Q2 2018.

  • On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to $153.0 million in Q2 2018; TTM through Mar 2019 was $153.0 million, a N/A change from a year earlier, with the FY2018 full-year figure at $183.0 million, down 51.23% from the prior year.
  • Dividends Paid - Common grew to $153.0 million in Q2 2018 per AMRX's latest filing, from $30.0 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $153.0 million in Q2 2018 and bottomed at $20.0 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 224.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.92 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 139.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Amneal Pharmaceuticals 5.68 Bn 5.67 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2018 153.00 Mn
Jun 30, 2018 153.00 Mn
Mar 31, 2018 30.00 Mn
Mar 31, 2018 30.00 Mn
Dec 31, 2017 20.00 Mn
Dec 31, 2017 20.00 Mn
Sep 30, 2017 60.00 Mn
Sep 30, 2017 60.00 Mn